title: Serum analysis of coagulation factors in IPF and NSIP.
abstract: Recent literature and our previous proteomic findings prompted us to study the coagulation system in idiopathic pulmonary fibrosis (IPF), the pathogenesis of which remains unclear. The aim of this study was to compare coagulation factors in idiopathic pulmonary fibrosis and idiopathic nonspecific interstitial pneumonia (NSIP) patients and healthy controls. Thirty-three IPF patients (23 acute exacerbation and 10 stable IPF patients), 7 NSIP patients, and 44 controls were enrolled. Concentrations of D-dimer, homocysteine, functional protein C, protein C antigen, free and total protein S antigen and activity, fibrinogen and factor VIIIc were analyzed in serum of patients and controls. The lupus anticoagulant (LAC) test was also performed. Factor VIIIc levels were significantly higher in acute exacerbation IPF patients than controls (p = 0.0001) and in stable IPF patients than controls (p = 0.002). Factor VIIIc levels were higher and PT levels were lower in acute exacerbation IPF patients who died after exacerbation than in patients who survived (p = 0.04 and p = 0.003, respectively). D-dimer, fibrinogen, and homocysteine levels were also significantly higher in IPF patients than controls (p < 0.01). Protein C activity was increased in acute exacerbation IPF patients than controls (p = 0.005). The LAC test was positive in seven IPF patients and negative in controls. Procoagulant status was demonstrated in IPF patients (mainly in acute exacerbation/IPF) than controls and NSIP patients, probably due to endothelial activation and microvascular injury. These preliminary results are of interest because of their potential implications in the pathogenesis and treatment of this disease.
authors.affiliation: Respiratory Diseases Section, Department of Clinical Medicine and Immunological Sciences, Siena University, Policlinico S. Maria Le Scotte Viale M. Bracci 16, 53100, Siena, Italy, bargagli2@gmail.com.
authors.forename: E
authors.initials: E
authors.lastname: Bargagli
authors.forename: C
authors.initials: C
authors.lastname: Madioni
authors.forename: N
authors.initials: N
authors.lastname: Bianchi
authors.forename: R M
authors.initials: RM
authors.lastname: Refini
authors.forename: R
authors.initials: R
authors.lastname: Cappelli
authors.forename: P
authors.initials: P
authors.lastname: Rottoli
mesh_terms: D001777:Blood Coagulation / Q000502:physiology*; D001779:Blood Coagulation Factors / Q000032:analysis*; D005169:Factor VIII / Q000032:analysis; D005260:Female; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis; D005340:Fibrinogen / Q000032:analysis; D006710:Homocysteine / Q000097:blood; D006801:Humans; D054988:Idiopathic Interstitial Pneumonias / Q000097:blood* / Q000401:mortality; D054990:Idiopathic Pulmonary Fibrosis / Q000097:blood* / Q000401:mortality; D016682:Lupus Coagulation Inhibitor / Q000097:blood; D008297:Male; D008875:Middle Aged; D011486:Protein C / Q000032:analysis; D017293:Protein S / Q000032:analysis
chemical_list: D001779:Blood Coagulation Factors; D005338:Fibrin Fibrinogen Degradation Products; D016682:Lupus Coagulation Inhibitor; D011486:Protein C; D017293:Protein S; C036309:fibrin fragment D; D006710:Homocysteine; D005169:Factor VIII; D005340:Fibrinogen
references.citation: Am J Clin Pathol. 2003 Apr;119(4):556-67
references.pmid: 12710128
references.citation: Crit Care Med. 2003 Apr;31(4 Suppl):S213-20
references.pmid: 12682443
references.citation: Chest. 2007 Nov;132(5):1652-8
references.pmid: 17998366
references.citation: Am J Physiol Lung Cell Mol Physiol. 2010 Jul;299(1):L3-7
references.pmid: 20418386
references.citation: Eur Respir J. 2005 Nov;26(5):948-68
references.pmid: 16264058
references.citation: Am J Respir Crit Care Med. 1998 Jun;157(6 Pt 1):1850-4
references.pmid: 9620917
references.citation: Lupus. 1999;8(7):560-4
references.pmid: 10483036
references.citation: Br J Pharmacol. 2008 Mar;153 Suppl 1:S367-78
references.pmid: 18223674
references.citation: Chest. 2005 Sep;128(3):1475-82
references.pmid: 16162746
references.citation: Rev Mal Respir. 2011 Apr;28(4):517-28
references.pmid: 21549906
references.citation: Med Clin (Barc). 2011 Apr 9;136(9):403-7
references.pmid: 20227733
references.citation: Arch Pathol Lab Med. 2011 Sep;135(9):1092-6
references.pmid: 21877992
references.citation: Clin Appl Thromb Hemost. 2000 Oct;6(4):202-5
references.pmid: 11030525
references.citation: Semin Immunopathol. 2012 Jan;34(1):63-72
references.pmid: 21809138
references.citation: Ann Biol Clin (Paris). 2011 Jul-Aug;69(4):411-8
references.pmid: 21896405
references.citation: Proteomics. 2006 Dec;6(23):6354-69
references.pmid: 17133372
references.citation: Thromb Haemost. 2008 Mar;99(3):494-501
references.pmid: 18327397
references.citation: Transl Res. 2011 Apr;157(4):191-9
references.pmid: 21420029
references.citation: Am J Respir Crit Care Med. 2010 Sep 15;182(6):826-33
references.pmid: 20508215
references.citation: Pneumonol Alergol Pol. 2008;76(4):225-8
references.pmid: 18785126
references.citation: Arthritis Rheum. 2009 Nov;60(11):3455-64
references.pmid: 19877031
references.citation: Br J Radiol. 2011 Jul;84(1003):581-92
references.pmid: 21697412
references.citation: Arthritis Rheum. 2011 May;63(5):1416-25
references.pmid: 21312187
references.citation: J Clin Invest. 2009 Sep;119(9):2550-63
references.pmid: 19652365
references.citation: Eur J Surg Oncol. 2005 Sep;31(7):798-802
references.pmid: 15993032
references.citation: Eur Respir J. 2007 Jun;29(6):1105-14
references.pmid: 17331968
references.citation: Hum Immunol. 2006 Apr-May;67(4-5):284-97
references.pmid: 16720208
references.citation: Am J Respir Crit Care Med. 2011 Mar 15;183(6):788-824
references.pmid: 21471066